These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34450283)

  • 1. Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine.
    Gill J; Chakraborti S; Bharti P; Sharma A
    Int J Infect Dis; 2021 Nov; 112():35-39. PubMed ID: 34450283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
    Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
    Elife; 2022 Feb; 11():. PubMed ID: 35103596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into chondroitin sulphate A binding Duffy-binding-like domains from Plasmodium falciparum: implications for intervention strategies against placental malaria.
    Gill J; Chitnis CE; Sharma A
    Malar J; 2009 Apr; 8():67. PubMed ID: 19374733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M; Duffy PE
    Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
    Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
    Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and new horizons toward a VAR2CSA-based placental malaria vaccine.
    Doritchamou JYA; Suurbaar J; Tuikue Ndam N
    Expert Rev Vaccines; 2021 Feb; 20(2):215-226. PubMed ID: 33472449
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.
    Ma R; Lian T; Huang R; Renn JP; Petersen JD; Zimmerberg J; Duffy PE; Tolia NH
    Nat Microbiol; 2021 Mar; 6(3):380-391. PubMed ID: 33452495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
    Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
    Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress and Insights Toward an Effective Placental Malaria Vaccine.
    Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; Nielsen MA
    Front Immunol; 2021; 12():634508. PubMed ID: 33717176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.
    Clausen TM; Christoffersen S; Dahlbäck M; Langkilde AE; Jensen KE; Resende M; Agerbæk MØ; Andersen D; Berisha B; Ditlev SB; Pinto VV; Nielsen MA; Theander TG; Larsen S; Salanti A
    J Biol Chem; 2012 Jul; 287(28):23332-45. PubMed ID: 22570492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
    Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A
    J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
    de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
    Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
    Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
    Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum.
    Duffy MF; Maier AG; Byrne TJ; Marty AJ; Elliott SR; O'Neill MT; Payne PD; Rogerson SJ; Cowman AF; Crabb BS; Brown GV
    Mol Biochem Parasitol; 2006 Aug; 148(2):117-24. PubMed ID: 16631964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria.
    Bordbar B; Tuikue Ndam N; Renard E; Jafari-Guemouri S; Tavul L; Jennison C; Gnidehou S; Tahar R; Gamboa D; Bendezu J; Menard D; Barry AE; Deloron P; Sabbagh A
    Infect Genet Evol; 2014 Jul; 25():81-92. PubMed ID: 24768682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
    Doritchamou JYA; Renn JP; Hviid L; Duffy PE
    PLoS Pathog; 2023 May; 19(5):e1011370. PubMed ID: 37228009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Invariant Protein That Colocalizes With VAR2CSA on Plasmodium falciparum-Infected Red Cells Binds to Chondroitin Sulfate A.
    Keitany GJ; Jenkins BJ; Obiakor HT; Daniel S; Muehlenbachs A; Semblat JP; Gamain B; Doritchamou JYA; Desai SA; MacDonald NJ; Narum DL; Morrison R; Saveria T; Vignali M; Oleinikov AV; Fried M; Duffy PE
    J Infect Dis; 2022 Jun; 225(11):2011-2022. PubMed ID: 34718641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
    Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccine.
    Ma R; Salinas ND; Orr-Gonzalez S; Richardson B; Ouahes T; Torano H; Jenkins BJ; Dickey TH; Neal J; Duan J; Morrison RD; Gittis AG; Doritchamou JYA; Zaidi I; Lambert LE; Duffy PE; Tolia NH
    PLoS Pathog; 2024 Mar; 20(3):e1011879. PubMed ID: 38437239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.